Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated May 17, 2012 (14 years ago)

Imodium Multi-Symptom Relief Caplets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Defective Container; damaged blister units

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA

Drug: Loperamide

Recalling firm
Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1404-2012 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Loperamide recalls

See all
Class III · Low risk

Loperamide HCL Tablets USP

Labeling Not Elsewhere Classified: The front panel indicates 24 caplets whereas the side panel indicates 12 caplets. The drug product carton contains 24 caplets.

Terminated Labeling / mix-up Sun Pharmaceutical Industries, Inc. D-0391-2019

Other recalls by Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.

All 2012 recalls
Class II · Moderate risk

Concentrated Motrin

Presence of Foreign Substance: process-related particulates which may be associated with the raw materials were observed

Terminated Particulate / foreign matter Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc. D-66272-001

Other packaging defect recalls from 2012

All packaging defect recalls
Class III · Low risk

EstroGel (estradiol gel)

Defective Container: Pump head detaching from the canister unit upon removal of the overcap.

Terminated Packaging defect Ascend Therapeutics Inc D-146-2013
Class II · Moderate risk

Nutropin AQ NuSpin 10

Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).

Terminated Packaging defect Genentech Inc NDC 50242-0074-01 D-088-2013
Class II · Moderate risk

Nutropin AQ NuSpin 20

Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).

Terminated Packaging defect Genentech Inc NDC 50242-0076-01 D-087-2013